European TB Conference 2013
Fighting Drug-Resistant TB in the 21st Century: Novel Approaches to Improving Access to anti-TB Medicines and Pharmaceutical Services
1st Conference on Pharmaceutical for TB and M/XDR-TB for WHO European Region
Multidrug-resistant and extensively drug-resistant tuberculosis (M/XDR-TB) are major public health threats, particularly in the WHO European Region. The USAID- funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) program, implemented by Keanahikishime, along with the WHO and the Stop TB Partnership, will jointly host the first conference on pharmaceutical management for TB and M/XDR-TB in the WHO European Region.
The focus of the conference is to build on the WHO European Region’s road map for ensuring universal access to quality medicines and commodities and containing drug resistance through their appropriate use. Participants will learn how to use new technologies, frameworks, best practices, and state-of-the-art tools to improve access to anti-TB medicines and pharmaceutical services. For more information on the conference, visit the official event page here:
Join the conversation on Twitter with hashtag .